The synthesis and study of physicochemical properties of 1,2,4-triazole derivatives containing the phenethyl group in position 5
DOI:
https://doi.org/10.24959/ophcj.20.175671Keywords:
1, 2, 4-triazole, synthesis, physicochemical propertiesAbstract
During the last decade, national and foreign scientists have been constantly examining an example of studying the physicochemical and biological properties of nitrogen containing heterocycles, particularly with the nucleus of 1,2,4-triazole. The main advantage of such substances is to exhibit low levels of acute toxicity with a wide spectrum of pharmacological activity. To date, a large number of medicines on the basis of 1,2,4-triazole has been created, namely fluconazole, voriconazole, anastrozole, itraconazole, and letrozole. Therefore, the creation of new molecules based on 1,2,4-triazole and the search for new biologically active compounds among them is an urgent task of modern synthetic and pharmaceutical chemistry.
Aim. To study some aspects of 5-phenethyl-1H-1,2,4-triazole-3-amine reactivity and investigate the physicochemical properties of synthesized compounds.
Results and discussion. A series of 1-alkyl(aryl)-N-(5-phenethyl-1H-1,2,4-triazolе-3-yl)methanimines has been synthesized and the reaction of their reduction has been studied. The structure and purity of the synthesized compounds have been confirmed by the complex of modern instrumental methods of analysis – elemental analysis, IR, 1H NMR spectroscopy, LC-MS.
Experimental part. The reaction of 5-phenethyl-1H-1,2,4-triazole-3-amine with aldehydes at the ambient temperature in acetic acid medium gave 1-alkyl(aryl)-N-(5-phenethyl-1H-1,2,4-triazolе-3-yl)methanimines. At the next stage, the selective reduction of the exocyclic C=N-group of 1-alkyl(aryl)-N-(5-phenethyl-1H-1,2,4-triazolе-3-yl)methanimines by the action of sodium borohydride in the dimethylformamide was carried out.
Conclusions. 13 new 1,2,4-triazole derivatives, namely 1-alkyl(aryl)-N-(5-phenethyl-1H-1,2,4-triazolе-3-yl)methanimines and arylmethyl-(5-phenethyl-1H-1,2,4-triazolе-3-yl)amines, have been obtained. The both structure and purity of the obtained substances have been confirmed by the complex of modern instrumental methods of analysis.
Received: 12.08.2019
Revised: 18.09.2019
Received after correction: 27.12.2019
Revised: 25.04.2020
Accepted: 29.05.2020
Supporting Agencies
- The themes of the Ministry of Public Health of Ukraine
- No. 0113U005084
- No. 0118U004249
Downloads
References
- Каплаушенко, А. Г.; Книш, Є. Г.; Панасенко, О. І.; Самелюк, Ю. Г.; Кучерявий, Ю. М.; Щербак, М. О.; Каплаушенко, Т. М.; Рудь, А. М.; Гуліна, Ю. С. Практичне значення та застосування похідних 1,2,4-тріазолу. Запорізький державний медичний університет: Запоріжжя, 2016.
- Каплаушенко, А. Г. Синтез, будова і біологічна активність похідних 4-моно- та 4,5-дизаміщених 1,2,4-триазол-3-тіону. Дисертація докт. фарм. наук, Запорізький державний медичний університет, Запоріжжя, 2012.
- Щербина, Р. О. Синтез, перетворення, фізико-хімічні та біологічні властивості похідних 2-(4Н-1,2,4-триазол-3-ілтіо)ацетальдегіду. Дисертація канд. фарм. наук, Запорізький державний медичний університет, Запоріжжя, 2014.
- Hulina, Yu. S.; Kaplaushenko, A. G. Synthesis and physical-chemical properties of 6-(5-(1Н-tetrazole-1-ylmethyl)-4-R-1,2,4-triazole-3-ylthio)pyridin-3-amines and 6-((5-(1Н-tetrazole-1-yl)methyl-4-R-1,2,4-triazole-3-ylthio)pyridin-3-yl)-(alk,ar,heter)ylmethanimines. Zaporozhye medical journal 2017, 19 (1), 100 – 104. https://doi.org/10.14739/2310-1210.2017.1.91726.
- Zhang, G.; Chen, Y.; Liao, L.; Lu, H.; Zhang, Z.; Ma, Q.; Yang, H.; Fan, G. 5-Amino-1H-1,2,4-triazole-3-carbohydrazide and its applications in the synthesis of energetic salts: a new strategy for constructing the nitrogen-rich cation based on the energetic moiety combination. Dalton Trans. 2018, 47 (38), 13391 – 13401. https://doi.org/10.1039/C8DT01760C.
- Asif, M.; Singh, A.; Khan, S. A.; Husain, A. Studies on new substituted pyridazinones: synthesis and biological evaluation. Braz. J. Pharm. Sci. 2018, 54 (3), 40 – 48.
- Tang, Y.; Yu, F.; Huang, L.; Hu, Z. The changes of antifungal susceptibilities caused by the phenotypic switching of Candida species in 229 patients with vulvovaginal candidiasis. J. Clin. Lab. Anal. 2019, 33 (1), e22644. https://doi.org/10.1002/jcla.22644.
- Gautier-Veyret, E.; Truffot, A.; Bailly, S.; Fonrose, X.; Thiebaut-Bertrand, A.; Tonini, J.; Cahn, J.-Y.; Stanke-Labesque, F. Inflammation is a potential risk factor of voriconazole overdose in hematological patients. Fundam. Clin. Pharmacol. 2019, 33 (2), 232 – 238. https://doi.org/10.1111/fcp.12422.
- Bhavsar, D.; Gajjar, J.; Sawant, K. Formulation and development of smart pH responsive mesoporous silica nanoparticles for breast cancer targeted delivery of anastrozole: In vitro and in vivo characterizations. Microporous Mesoporous Mater. 2019, 279, 107 – 116. https://doi.org/10.1016/j.micromeso.2018.12.026.
- Lindberg, E.; Hammarström, H.; Ataollahy, N.; Kondori, N. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports 2019, 9 (1), 3838. https://doi.org/10.1038/s41598-019-40280-8.
- Mejia, R. B.; Summers, K. M.; Kresowik, J. D.; Van Voorhis, B. J. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil. Steril. 2019, 111 (3), 571 – 578.e1. https://doi.org/10.1016/j.fertnstert.2018.11.030.
- Світлична, Н. В.; Бородіна, В. В.; Ліпсон, В. В.; Мусатов В. І. Синтез 7-арил-6,7-дигідротетразоло[1,5-a]піримідин-5(4H)-онів. Журнал органічної та фармацевтичної хімії 2014, 12 (1), 47 – 50. https://doi.org/10.24959/ophcj.14.785.
- Казицына, Л. Α.; Куплетская, Н. Б. Применение УФ-, ИК-, ЯМР- и масс-спектроскопии в органической химии. Издательство Московского университета: Москва, 1979.
- Державна фармакопея України. 2е вид.; Український науковий фармакопейний центр якості лікарських засобів: Харків, 2015; Vol. 1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).